Colonoscopic surveillance in ulcerative colitis has costs and benefits beyond cancer prevention, which might influence program efficacy.
Dr Matthew Rutter from England assessed the more intangible aspects of surveillance.
The investigative team sent a questionnaire to all patients on the St. Mark's colitis surveillance program.
Data on quality of life, complications, and preferences for surveillance and information were collated with demographics and surveillance history.
The investigations team had 281 of 329 patients respond.
The team noted that the Median Euroqol score was 80.
There were no perforations, and bleeding rate was less than 1%.
| Not all patients would necessarily opt for surveillance in its current form|
|Diseases of the Colon & Rectum|
No transfusions, endoscopic intervention, or surgeries were required.
The team found that 24% were frightened before colonoscopies, correlating with anxiety.
The investigators observed that 60% of patients found colonoscopies comfortable, and patients reported that experienced colonoscopists caused less discomfort.
About 84% of patients thought they had received appropriate amounts of information.
In addition, the team noted that 98% of patients believed surveillance important, 96% thought surveillance gave them reassurance.
The investigators identified that 68% of patients believed surveillance greatly reduced their cancer risk.
Regarding cancer risk management, 33% of patients indicated they might not necessarily opt for surveillance in its current form.
Dr Rutter's team commented, “Colonoscopic surveillance is well tolerated with an extremely low complication rate.”
“Patients have a good quality of life, and believe surveillance is important and reassuring.”
“However, many are anxious before their colonoscopy.”
”The majority are happy with information quantity and quality, although none thought they received too much.”